# LXP Industrial Trust: financial statements, quarterly

LXP · NYSE · CIK 910108 · [Real estate](/sectors/real-estate.md) · fiscal year ends Dec 31

Pages: [Overview](/companies/lxp.md) · [Financials](/companies/lxp/financials.md) · [Filings](/companies/lxp/filings.md) · [Insiders](/companies/lxp/insiders.md)

Standardized line items from XBRL company facts. Each value links to its filing; d marks a value derived from year-to-date figures. Other view: [annual](/companies/lxp/financials.md?period=annual).

## Income statement

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Revenue | $m | [1.6](/filings/0001444838-24-000116.md) | [1.1 d](/filings/0000910108-26-000009.md) | [1.0](/filings/0000910108-25-000020.md) | [1.0](/filings/0000910108-25-000041.md) | [1.0](/filings/0000910108-25-000067.md) | [1.0 d](/filings/0000910108-26-000009.md) | [1.0](/filings/0000910108-26-000030.md) | [1.0](/filings/0000910108-26-000045.md) | [1.1](/filings/0000910108-25-000067.md) | [1.1 d](/filings/0000910108-26-000009.md) | [1.0](/filings/0000910108-26-000030.md) | [1.0](/filings/0000910108-26-000045.md) |
| Cost of revenue | $m | [14.7](/filings/0001444838-24-000116.md) | [12.7 d](/filings/0000910108-26-000009.md) | [15.2](/filings/0000910108-25-000020.md) | [15.5](/filings/0000910108-25-000041.md) | [15.0](/filings/0000910108-25-000067.md) | [14.8 d](/filings/0000910108-26-000009.md) | [17.1](/filings/0000910108-26-000030.md) | [15.9](/filings/0000910108-26-000045.md) | [15.3](/filings/0000910108-25-000067.md) | [16.0 d](/filings/0000910108-26-000009.md) | [16.7](/filings/0000910108-26-000030.md) | [16.2](/filings/0000910108-26-000045.md) |
| Interest expense | $m | [11.0](/filings/0001444838-23-000053.md) | [13.9 d](/filings/0001444838-24-000053.md) | [17.0](/filings/0001444838-24-000070.md) | [17.6](/filings/0000910108-25-000041.md) | [16.0](/filings/0000910108-25-000067.md) | [15.9 d](/filings/0000910108-26-000009.md) | [16.3](/filings/0000910108-26-000030.md) | [16.5](/filings/0000910108-26-000045.md) | [16.1](/filings/0000910108-25-000067.md) | [14.1 d](/filings/0000910108-26-000009.md) | [13.2](/filings/0000910108-26-000030.md) | [13.3](/filings/0000910108-26-000045.md) |
| Income tax | $m | [0.2](/filings/0001444838-24-000116.md) | [(0.5) d](/filings/0000910108-26-000009.md) | [0.1](/filings/0000910108-25-000020.md) | [0.1](/filings/0000910108-25-000041.md) | [0.0](/filings/0000910108-25-000067.md) | [(0.1) d](/filings/0000910108-26-000009.md) | [0.2](/filings/0000910108-26-000030.md) | [0.2](/filings/0000910108-26-000045.md) | [0.2](/filings/0000910108-25-000067.md) | [(0.4) d](/filings/0000910108-26-000009.md) | [0.1](/filings/0000910108-26-000030.md) | [0.2](/filings/0000910108-26-000045.md) |
| Net income | $m | [12.7](/filings/0001444838-24-000116.md) | [14.6 d](/filings/0000910108-26-000009.md) | [(0.3)](/filings/0000910108-25-000020.md) | [5.4](/filings/0000910108-25-000041.md) | [6.3](/filings/0000910108-25-000067.md) | [33.0 d](/filings/0000910108-26-000009.md) | [19.0](/filings/0000910108-26-000030.md) | [29.1](/filings/0000910108-26-000045.md) | [36.3](/filings/0000910108-25-000067.md) | [28.8 d](/filings/0000910108-26-000009.md) | [(0.2)](/filings/0000910108-26-000030.md) | [0.1](/filings/0000910108-26-000045.md) |
| Diluted EPS | $ per share | [0.04](/filings/0001444838-24-000116.md) | not reported | [(0.01)](/filings/0000910108-25-000020.md) | [0.01](/filings/0000910108-25-000041.md) | [0.02](/filings/0000910108-25-000067.md) | not reported | [0.30](/filings/0000910108-26-000030.md) | [0.47](/filings/0000910108-26-000045.md) | [0.12](/filings/0000910108-25-000067.md) | not reported | [(0.03)](/filings/0000910108-26-000030.md) | [(0.03)](/filings/0000910108-26-000045.md) |
| Basic EPS | $ per share | [0.04](/filings/0001444838-24-000116.md) | not reported | [(0.01)](/filings/0000910108-25-000020.md) | [0.01](/filings/0000910108-25-000041.md) | [0.02](/filings/0000910108-25-000067.md) | not reported | [0.30](/filings/0000910108-26-000030.md) | [0.47](/filings/0000910108-26-000045.md) | [0.12](/filings/0000910108-25-000067.md) | not reported | [(0.03)](/filings/0000910108-26-000030.md) | [(0.03)](/filings/0000910108-26-000045.md) |

- Revenue: us-gaap:RevenueFromContractWithCustomerExcludingAssessedTax
- Cost of revenue: us-gaap:CostOfGoodsAndServicesSold
- Interest expense: us-gaap:InterestExpense, us-gaap:InterestExpenseNonoperating
- Income tax: us-gaap:IncomeTaxExpenseBenefit
- Net income: us-gaap:NetIncomeLoss
- Diluted EPS: us-gaap:EarningsPerShareDiluted
- Basic EPS: us-gaap:EarningsPerShareBasic

## Balance sheet

| Line item | Unit | Q3 FY2023 (2023-09-30) | FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Cash and equivalents | $m | [35.4](/filings/0001444838-24-000116.md) | [199](/filings/0000910108-26-000009.md) | [163](/filings/0000910108-25-000020.md) | [48.7](/filings/0000910108-25-000041.md) | [55.0](/filings/0000910108-25-000067.md) | [102](/filings/0000910108-26-000045.md) | [70.9](/filings/0000910108-26-000030.md) | [71.0](/filings/0000910108-26-000045.md) | [230](/filings/0000910108-25-000067.md) | [170](/filings/0000910108-26-000045.md) | [130](/filings/0000910108-26-000030.md) | [18.0](/filings/0000910108-26-000045.md) |
| Total assets | $m | [3,929](/filings/0001444838-23-000053.md) | [4,193](/filings/0001444838-25-000023.md) | [4,156](/filings/0001444838-24-000070.md) | [3,886](/filings/0001444838-24-000090.md) | [3,854](/filings/0001444838-24-000116.md) | [3,843](/filings/0000910108-26-000009.md) | [3,760](/filings/0000910108-25-000020.md) | [3,717](/filings/0000910108-25-000041.md) | [3,709](/filings/0000910108-25-000067.md) | [3,537](/filings/0000910108-26-000045.md) | [3,467](/filings/0000910108-26-000030.md) | [3,464](/filings/0000910108-26-000045.md) |
| Total liabilities | $m | [1,635](/filings/0001444838-23-000053.md) | [1,927](/filings/0001444838-25-000023.md) | [1,936](/filings/0001444838-24-000070.md) | [1,725](/filings/0001444838-24-000090.md) | [1,728](/filings/0001444838-24-000116.md) | [1,723](/filings/0000910108-26-000009.md) | [1,663](/filings/0000910108-25-000020.md) | [1,631](/filings/0000910108-25-000041.md) | [1,635](/filings/0000910108-25-000067.md) | [1,489](/filings/0000910108-26-000045.md) | [1,468](/filings/0000910108-26-000030.md) | [1,503](/filings/0000910108-26-000045.md) |
| Long-term debt | $m | not reported | not reported | not reported | not reported | not reported | [1,570](/filings/0000910108-26-000009.md) | [1,520](/filings/0000910108-25-000020.md) | [1,491](/filings/0000910108-25-000041.md) | [1,491](/filings/0000910108-25-000067.md) | [1,351](/filings/0000910108-26-000045.md) | [1,349](/filings/0000910108-26-000030.md) | [1,363](/filings/0000910108-26-000045.md) |
| Shareholders' equity | $m | [2,256](/filings/0001444838-23-000053.md) | [2,232](/filings/0001444838-25-000023.md) | [2,189](/filings/0001444838-24-000070.md) | [2,134](/filings/0001444838-24-000090.md) | [2,100](/filings/0001444838-24-000116.md) | [2,098](/filings/0000910108-26-000009.md) | [2,075](/filings/0000910108-25-000020.md) | [2,064](/filings/0000910108-25-000041.md) | [2,061](/filings/0000910108-25-000067.md) | [2,037](/filings/0000910108-26-000045.md) | [1,988](/filings/0000910108-26-000030.md) | [1,948](/filings/0000910108-26-000045.md) |

- Cash and equivalents: us-gaap:CashAndCashEquivalentsAtCarryingValue
- Total assets: us-gaap:Assets
- Total liabilities: us-gaap:Liabilities
- Long-term debt: us-gaap:LongTermDebt
- Shareholders' equity: us-gaap:StockholdersEquity

## Cash flow

| Line item | Unit | Q3 FY2023 (2023-09-30) | Q4 FY2023 (2023-12-31) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q4 FY2024 (2024-12-31) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q4 FY2025 (2025-12-31) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Operating cash flow | $m | [60.9 d](/filings/0001444838-24-000116.md) | [55.9 d](/filings/0000910108-26-000009.md) | [38.9](/filings/0000910108-25-000020.md) | [38.5 d](/filings/0000910108-25-000041.md) | [64.6 d](/filings/0000910108-25-000067.md) | [69.2 d](/filings/0000910108-26-000009.md) | [39.0](/filings/0000910108-26-000030.md) | [44.3 d](/filings/0000910108-26-000045.md) | [63.5 d](/filings/0000910108-25-000067.md) | [41.9 d](/filings/0000910108-26-000009.md) | [37.5](/filings/0000910108-26-000030.md) | [48.7 d](/filings/0000910108-26-000045.md) |
| Dividends paid | $m | [37.9 d](/filings/0001444838-24-000116.md) | [37.9 d](/filings/0000910108-26-000009.md) | [39.5](/filings/0000910108-25-000020.md) | [39.5 d](/filings/0000910108-25-000041.md) | [39.5 d](/filings/0000910108-25-000067.md) | [39.6 d](/filings/0000910108-26-000009.md) | [41.0](/filings/0000910108-26-000030.md) | [41.1 d](/filings/0000910108-26-000045.md) | [41.1 d](/filings/0000910108-25-000067.md) | [41.1 d](/filings/0000910108-26-000009.md) | [43.0](/filings/0000910108-26-000030.md) | [42.3 d](/filings/0000910108-26-000045.md) |
| Share repurchases | $m | [0.0 d](/filings/0001444838-23-000053.md) | [0.0 d](/filings/0000910108-26-000009.md) | not reported | not reported | not reported | not reported | [0.0](/filings/0000910108-26-000030.md) | [0.0 d](/filings/0000910108-26-000045.md) | not reported | not reported | [15.8](/filings/0000910108-26-000030.md) | [0.0 d](/filings/0000910108-26-000045.md) |

- Operating cash flow: us-gaap:NetCashProvidedByUsedInOperatingActivities
- Dividends paid: us-gaap:PaymentsOfDividends
- Share repurchases: us-gaap:PaymentsForRepurchaseOfCommonStock

## Shares

| Line item | Unit | Q3 FY2022 (2022-09-30) | Q1 FY2023 (2023-03-31) | Q2 FY2023 (2023-06-30) | Q3 FY2023 (2023-09-30) | Q1 FY2024 (2024-03-31) | Q2 FY2024 (2024-06-30) | Q3 FY2024 (2024-09-30) | Q1 FY2025 (2025-03-31) | Q2 FY2025 (2025-06-30) | Q3 FY2025 (2025-09-30) | Q1 FY2026 (2026-03-31) | Q2 FY2026 (2026-06-30) |
| --- | --- | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: | ---: |
| Diluted shares (weighted) | millions of shares | [279](/filings/0001444838-23-000053.md) | [291](/filings/0001444838-24-000070.md) | [291](/filings/0001444838-24-000090.md) | [291](/filings/0001444838-24-000116.md) | [291](/filings/0000910108-25-000020.md) | [292](/filings/0000910108-25-000041.md) | [292](/filings/0000910108-25-000067.md) | [58.5](/filings/0000910108-26-000030.md) | [58.4](/filings/0000910108-26-000045.md) | [293](/filings/0000910108-25-000067.md) | [58.2](/filings/0000910108-26-000030.md) | [58.1](/filings/0000910108-26-000045.md) |

- Diluted shares (weighted): us-gaap:WeightedAverageNumberOfDilutedSharesOutstanding

Shares outstanding: 58,957,264 at 2026-07-28, from the cover of the [10-Q filed 2026-07-29](/filings/0000910108-26-000045.md) (dei:EntityCommonStockSharesOutstanding).

Source: SEC EDGAR, XBRL company facts. Last ingested by Listed: Oct 24, 2026, 15:28 ET. No prices; not investment advice.